Effects of the traditional Mediterranean diet on adiponectin and leptin concentrations in men and premenopausal women: do sex differences exist?

A Bédard, A Tchernof, B Lamarche, L Corneau, S Dodin, S Lemieux, A Bédard, A Tchernof, B Lamarche, L Corneau, S Dodin, S Lemieux

Abstract

Background/objectives: Most of the interventional studies have investigated the impact of the diet on adiponectin and leptin concentrations only in men or in women. Consequently, it is still unknown whether the consumption of a healthy diet influences in a sex-specific manner these adipocytokines. We examined sex differences in the effects of the Mediterranean diet (MedDiet) on adiponectin and leptin concentrations, and determined whether changes in these adipocytokines are associated with changes in cardiovascular risk factors in both sexes.

Subjects/methods: Participants were 38 men and 32 premenopausal women (24-53 years) with slightly elevated low-density lipoprotein cholesterol concentrations (3.4-4.9 mmol/l) or total cholesterol/high-density lipoprotein cholesterol (HDL-C)⩾5.0. Adiponectin, leptin and cardiovascular risk factors were measured before and after a 4-week fully controlled isoenergetic MedDiet.

Results: Adiponectin concentration decreased in response to the MedDiet, but this decrease reached statistical significance only in men (P<0.001 for men and P=0.260 for women; sex-by-time interaction, P=0.072). Adjustments for body weight or waist circumference did not change results obtained. Changes in adiponectin were positively associated with concomitant variations in HDL-C in men (r=0.52, P=0.003) and with variations in apolipoprotein A-1 and insulin sensitivity as calculated by both the homeostasis model assessment index for insulin sensitivity and Cederholm indices in women (respectively, r=0.44, P=0.021; r=0.79, P<0.001 and r=0.47, P=0.020). The MedDiet had no impact on leptin and the leptin-to-adiponectin ratio in both sexes.

Conclusions: Results suggest a sex difference in adiponectin response to the short-term consumption of the MedDiet, with only men experiencing a decrease. Also sex-specific patterns of associations between changes in adiponectin concentration and changes in cardiovascular risk factors were observed.

Trial registration: ClinicalTrials.gov NCT01293344.

References

    1. Clin Endocrinol (Oxf). 1997 Jul;47(1):101-6
    1. Nutr Res Rev. 2008 Dec;21(2):117-33
    1. Br J Nutr. 2012 Oct 28;108(8):1428-34
    1. Metab Syndr Relat Disord. 2011 Feb;9(1):19-23
    1. Cardiol Res Pract. 2010 Dec 20;2011:293916
    1. Lancet. 2003 Jan 18;361(9353):226-8
    1. Obesity (Silver Spring). 2010 Jan;18(1):196-201
    1. Clin Chem. 1972 Jun;18(6):499-502
    1. Arch Med Res. 1999 Jan-Feb;30(1):19-22
    1. Diabetologia. 2009 Nov;52(11):2345-2349
    1. JAMA. 2003 Apr 9;289(14):1799-804
    1. Int J Obes (Lond). 2007 Jul;31(7):1126-33
    1. Nutr J. 2004 Sep 13;3:13
    1. Diabetes Care. 2006 Nov;29(11):2498-503
    1. Curr Pharm Des. 2010 Jun;16(17):1896-901
    1. Am J Hum Biol. 2012 Sep-Oct;24(5):595-601
    1. Diabetes Care. 1999 Jan;22(1):65-70
    1. Diabetes Res Clin Pract. 1990 Oct;10(2):167-75
    1. Diabetes Res Clin Pract. 2009 Apr;84(1):27-33
    1. Diabetologia. 2012 Sep;55(9):2319-26
    1. Diabetes Obes Metab. 2007 May;9(3):246-58
    1. J Nutr Biochem. 2010 Apr;21(4):285-9
    1. Recent Prog Horm Res. 2004;59:267-85
    1. Am J Clin Nutr. 2006 Aug;84(2):328-35
    1. Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):628-35
    1. JAMA. 2004 Sep 22;292(12):1440-6
    1. Clin Chem. 1978 Jun;24(6):853-6
    1. Schweiz Med Wochenschr. 1971 May 1;101(17):615-8
    1. J Clin Endocrinol Metab. 1996 Oct;81(10):3599-603
    1. J Clin Endocrinol Metab. 1971 Nov;33(5):732-8
    1. Diabetes Care. 2005 Sep;28(9):2181-6
    1. J Am Coll Cardiol. 2009 Jan 13;53(2):167-75
    1. Am J Med Sci. 2013 Jun;345(6):455-61

Source: PubMed

3
Iratkozz fel